190 related articles for article (PubMed ID: 10510403)
1. Nephritogenic lambda light chain dimer: a unique human miniautoantibody against complement factor H.
Jokiranta TS; Solomon A; Pangburn MK; Zipfel PF; Meri S
J Immunol; 1999 Oct; 163(8):4590-6. PubMed ID: 10510403
[TBL] [Abstract][Full Text] [Related]
2. Activation of the alternative pathway of complement by monoclonal lambda light chains in membranoproliferative glomerulonephritis.
Meri S; Koistinen V; Miettinen A; Törnroth T; Seppälä IJ
J Exp Med; 1992 Apr; 175(4):939-50. PubMed ID: 1532415
[TBL] [Abstract][Full Text] [Related]
3. Anti-factor H autoantibodies in C3 glomerulopathies and in atypical hemolytic uremic syndrome: one target, two diseases.
Blanc C; Togarsimalemath SK; Chauvet S; Le Quintrec M; Moulin B; Buchler M; Jokiranta TS; Roumenina LT; Fremeaux-Bacchi V; Dragon-Durey MA
J Immunol; 2015 Jun; 194(11):5129-38. PubMed ID: 25917093
[TBL] [Abstract][Full Text] [Related]
4. Molecular cloning and characterization of human thyroid peroxidase autoantibodies of lambda light chain type.
Portolano S; Prummel MF; Rapoport B; McLachlan SM
Mol Immunol; 1995 Oct; 32(14-15):1157-69. PubMed ID: 8544864
[TBL] [Abstract][Full Text] [Related]
5. Characterization of a factor H mutation that perturbs the alternative pathway of complement in a family with membranoproliferative GN.
Wong EK; Anderson HE; Herbert AP; Challis RC; Brown P; Reis GS; Tellez JO; Strain L; Fluck N; Humphrey A; Macleod A; Richards A; Ahlert D; Santibanez-Koref M; Barlow PN; Marchbank KJ; Harris CL; Goodship TH; Kavanagh D
J Am Soc Nephrol; 2014 Nov; 25(11):2425-33. PubMed ID: 24722444
[TBL] [Abstract][Full Text] [Related]
6. Factor H autoantibodies in membranoproliferative glomerulonephritis.
Goodship TH; Pappworth IY; Toth T; Denton M; Houlberg K; McCormick F; Warland D; Moore I; Hunze EM; Staniforth SJ; Hayes C; Cavalcante DP; Kavanagh D; Strain L; Herbert AP; Schmidt CQ; Barlow PN; Harris CL; Marchbank KJ
Mol Immunol; 2012 Oct; 52(3-4):200-6. PubMed ID: 22721707
[TBL] [Abstract][Full Text] [Related]
7. Bovine IgM antibodies with exceptionally long complementarity-determining region 3 of the heavy chain share unique structural properties conferring restricted VH + Vlambda pairings.
Saini SS; Farrugia W; Ramsland PA; Kaushik AK
Int Immunol; 2003 Jul; 15(7):845-53. PubMed ID: 12807823
[TBL] [Abstract][Full Text] [Related]
8. Nephritic factors predispose to chronic glomerulonephritis.
West CD
Am J Kidney Dis; 1994 Dec; 24(6):956-63. PubMed ID: 7985676
[TBL] [Abstract][Full Text] [Related]
9. Molecular localization of human IgG anti-F(ab')2 reactivity with variable- and constant-region lambda light-chain epitopes.
Williams RC; Malone CC; Silvestris F; Solomon A
J Clin Immunol; 1995 Nov; 15(6):349-62. PubMed ID: 8576321
[TBL] [Abstract][Full Text] [Related]
10. Autoimmune abnormalities of the alternative complement pathway in membranoproliferative glomerulonephritis and C3 glomerulopathy.
Noris M; Donadelli R; Remuzzi G
Pediatr Nephrol; 2019 Aug; 34(8):1311-1323. PubMed ID: 29948306
[TBL] [Abstract][Full Text] [Related]
11. Chemical and serologic characterization of human lambda VIII light chains.
Solomon A; Weiss DT; Murphy C; Fu SM; Robbins DL
J Immunol; 1994 Aug; 153(4):1658-64. PubMed ID: 8046238
[TBL] [Abstract][Full Text] [Related]
12. Identification and characterization of a human Vlambda5 (T1) germline gene that encodes structurally unique lambda light chains.
Solomon A; Weiss DT; Schell M; Ringelberg C; Ch'ang LY; Klebig ML
Mol Immunol; 1997 Apr; 34(6):463-70. PubMed ID: 9307062
[TBL] [Abstract][Full Text] [Related]
13. The major autoantibody epitope on factor H in atypical hemolytic uremic syndrome is structurally different from its homologous site in factor H-related protein 1, supporting a novel model for induction of autoimmunity in this disease.
Bhattacharjee A; Reuter S; Trojnár E; Kolodziejczyk R; Seeberger H; Hyvärinen S; Uzonyi B; Szilágyi Á; Prohászka Z; Goldman A; Józsi M; Jokiranta TS
J Biol Chem; 2015 Apr; 290(15):9500-10. PubMed ID: 25659429
[TBL] [Abstract][Full Text] [Related]
14. Deletion of Lys224 in regulatory domain 4 of Factor H reveals a novel pathomechanism for dense deposit disease (MPGN II).
Licht C; Heinen S; Józsi M; Löschmann I; Saunders RE; Perkins SJ; Waldherr R; Skerka C; Kirschfink M; Hoppe B; Zipfel PF
Kidney Int; 2006 Jul; 70(1):42-50. PubMed ID: 16612335
[TBL] [Abstract][Full Text] [Related]
15. Hereditary porcine membranoproliferative glomerulonephritis type II is caused by factor H deficiency.
Høgåsen K; Jansen JH; Mollnes TE; Hovdenes J; Harboe M
J Clin Invest; 1995 Mar; 95(3):1054-61. PubMed ID: 7883953
[TBL] [Abstract][Full Text] [Related]
16. Dense deposit disease associated with monoclonal gammopathy of undetermined significance.
Sethi S; Sukov WR; Zhang Y; Fervenza FC; Lager DJ; Miller DV; Cornell LD; Krishnan SG; Smith RJ
Am J Kidney Dis; 2010 Nov; 56(5):977-82. PubMed ID: 20832153
[TBL] [Abstract][Full Text] [Related]
17. A properdin dependent nephritic factor slowly activating C3, C5, and C9 in membranoproliferative glomerulonephritis, types I and III.
Clardy CW; Forristal J; Strife CF; West CD
Clin Immunol Immunopathol; 1989 Mar; 50(3):333-47. PubMed ID: 2917424
[TBL] [Abstract][Full Text] [Related]
18. Atypical hemolytic uremic syndrome-associated variants and autoantibodies impair binding of factor h and factor h-related protein 1 to pentraxin 3.
Kopp A; Strobel S; Tortajada A; Rodríguez de Córdoba S; Sánchez-Corral P; Prohászka Z; López-Trascasa M; Józsi M
J Immunol; 2012 Aug; 189(4):1858-67. PubMed ID: 22786770
[TBL] [Abstract][Full Text] [Related]
19. Complement factor H: using atomic resolution structure to illuminate disease mechanisms.
Barlow PN; Hageman GS; Lea SM
Adv Exp Med Biol; 2008; 632():117-42. PubMed ID: 19025119
[TBL] [Abstract][Full Text] [Related]
20. Heat-induced formation of a specific binding site for self-assembled Congo Red in the V domain of immunoglobulin L chain lambda.
Piekarska B; Konieczny L; Rybarska J; Stopa B; Zemanek G; Szneler E; Król M; Nowak M; Roterman I
Biopolymers; 2001 Nov; 59(6):446-56. PubMed ID: 11598879
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
